{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:00:07Z","timestamp":1773284407376,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.urolonc.2020.10.016","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T12:11:48Z","timestamp":1604578308000},"page":"432.e11-432.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings"],"prefix":"10.1016","volume":"39","author":[{"given":"Juan","family":"Morote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Borque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Celma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarai","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s M.","family":"de Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda E.","family":"Semidey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Regis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Trilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.10.016_bib0001","unstructured":"Mottet N, van den Bergh RCN, Briesrs E, Conford P, De Santis M, Fanti S, et al. Guidelines on prostate cancer. http:\/\/uroweb.org\/guideline\/prostatecancer\/2020."},{"key":"10.1016\/j.urolonc.2020.10.016_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11934-018-0828-6","article-title":"Improving the specificity of PSA screening with serum and urine markers","volume":"19","author":"Kearns","year":"2018","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.urolonc.2019.12.013","article-title":"Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result","volume":"38","author":"Morote","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0005","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00345-019-02946-w","article-title":"How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies","volume":"38","author":"Borque-Fernando","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.urology.2017.04.021","article-title":"Atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in the era of multiparametric magnetic resonance imaging: a contemporary review","volume":"107","author":"Manning","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0007","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pros.23234","article-title":"Clinical significance of proliferative inflammatory atrophy in negative prostatic biopsies","volume":"76","author":"Servian","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/pcan.2017.30","article-title":"The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens","volume":"20","author":"Moreira","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0009","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging \u2013 reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0011","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eururo.2019.04.043","article-title":"Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis","volume":"76","author":"Kasivisvanathan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0012","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0013","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.juro.2011.03.147","article-title":"Characterizing clinically significant prostate cancer using template prostate mapping biopsy","volume":"186","author":"Ahmed","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0014","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.acuro.2019.01.010","article-title":"In search for risk predictors at the microscopic scenario of a negative biopsy. A systematic review","volume":"43","author":"Schwartzmann","year":"2019","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0015","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1464-410X.2011.10532.x","article-title":"Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy","volume":"109","author":"Roscigno","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrurol.2017.134","article-title":"Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy","volume":"15","author":"Tosoian","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0018","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/apm.12291","article-title":"Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy","volume":"122","author":"Sailer","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0019","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00428-017-2123-1","article-title":"Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer","volume":"470","author":"Giunchi","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0020","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/pros.23047","article-title":"Clinical significance of proliferative inflammatory atrophy finding in prostatic biopsies","volume":"75","author":"Servian","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0021","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.28349","article-title":"Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study: inflammation and prostate cancer","volume":"120","author":"Moreira","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0022","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2015.05.103","article-title":"Baseline prostate atrophy is associated with reduced risk of prostate cancer in men undergoing repeat prostate biopsy","volume":"194","author":"Moreira","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0023","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/pros.23041","article-title":"Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: results from the REDUCE study: inflammation and prostate cancer volume","volume":"75","author":"Moreira","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.anndiagpath.2016.04.010","article-title":"Inflammation and focal atrophy in prostate needle biopsy cores and association to prostatic adenocarcinoma","volume":"24","author":"Benedetti","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41391-017-0012-y","article-title":"Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy","volume":"21","author":"Moreira","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0026","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2017.08.040","article-title":"Incidence of clinically significant prostate cancer after a diagnosis of atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, or benign tissue","volume":"110","author":"Wiener","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2018.05.011","article-title":"Initial diagnosis of insignificant cancer, high-grade prostatic intraepithelial neoplasia, atypical small acinar proliferation, and negative have the same rate of upgrade to a Gleason score of 7 or higher on repeat prostate biopsy","volume":"79","author":"Prathibha","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0028","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0029","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/JU.0000000000000622","article-title":"External validation and comparison of prostate cancer risk calculators incorporating multiparametric magnetic resonance imaging for prediction of clinically significant prostate cancer","volume":"203","author":"Saba","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.10.016_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:22:44Z","timestamp":1761042164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920304889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1078143920304889"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.10.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}